proxyvotesnow.com

Home › Asset managers › Compare 2025-2026 › Franklin Templeton vs Brighthouse

Franklin Templeton vs Brighthouse: how alike they voted, 2025-2026

98.7% When both took a single position, they voted the same way on 98.7% of 25,577 items (25,254 the same, 323 different). 7,905 items where at least one of them split its funds are listed separately below. Both voted on 33,482 items in all.

Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.

Franklin Templeton 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
Common itemsSame DifferSplit (not in %)Same position Fund-level
All ballot items 33,48225,254323 7,90598.7%90.6%
Board proposals 27,57020,122273 7,17598.7%90.0%
E&S shareholder proposals 16600 166n/a41.8%
Other items 5,7465,13250 56499.0%94.9%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

7,905 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

CompanyMeetingProposalOn the ballot from Board recommendedFranklin TempletonBrighthouse
ACUSHNET HOLDINGS CORP. June 8, 2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.
Audit-related
Board For FOR
1 fund
Split
3 FOR, 1 ABSTAIN
ADAPTIVE BIOTECHNOLOGIES CORPORATION June 5, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;
Say-on-Pay
Board For FOR
2 funds
Split
3 FOR, 1 ABSTAIN
ADAPTIVE BIOTECHNOLOGIES CORPORATION June 5, 2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026;
Audit-related
Board For FOR
2 funds
Split
3 FOR, 1 ABSTAIN
ADIDAS AG May 7, 2026 APPROVE MANAGEMENT BOARD REMUNERATION POLICY
Say-on-Pay
Board For AGAINST
6 funds
Split
1 FOR, 2 AGAINST
ADIDAS AG May 7, 2026 REELECT NASSEF SAWIRIS TO THE SUPERVISORY BOARD
Director Elections
Board For AGAINST
6 funds
Split
1 FOR, 2 AGAINST
ADMA BIOLOGICS, INC. June 2, 2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
1 fund
Split
4 FOR, 2 ABSTAIN
ADMA BIOLOGICS, INC. June 2, 2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Alison C. Finger
Director Elections
Board For FOR
1 fund
Split
3 FOR, 3 WITHHOLD
ADMA BIOLOGICS, INC. June 2, 2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
1 fund
Split
4 FOR, 2 ABSTAIN
ADOBE INC. April 15, 2026 Approve the 2019 Equity Incentive Plan, as amended, to increase the available share reserve by 12 million shares.
Compensation
Board For FOR
5 funds
Split
4 FOR, 7 ABSTAIN
ADOBE INC. April 15, 2026 Approve, on an advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For Split
2 FOR, 7 AGAINST
Split
4 AGAINST, 7 ABSTAIN
ADOBE INC. April 15, 2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending on November 27, 2026.
Audit-related
Board For FOR
5 funds
Split
4 FOR, 7 ABSTAIN
ADT INC. May 27, 2026 Advisory vote to approve the compensation of our named executive officers.
Say-on-Pay
Board For FOR
3 funds
Split
3 FOR, 2 ABSTAIN
ADT INC. May 27, 2026 Ratification of the appointment of PricewaterhouseCoopers LLP to be the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
2 funds
Split
3 FOR, 2 ABSTAIN
ADT Inc. May 27, 2026 Election of Directors To be elected for terms expiring in 2027: Sigal Zarmi
Director Elections
Board For FOR
2 funds
Split
3 FOR, 2 WITHHOLD
ADT Inc. May 27, 2026 Election of Directors To be elected for terms expiring in 2027: Thomas Gartland
Director Elections
Board For FOR
2 funds
Split
3 FOR, 2 WITHHOLD
ADTALEM GLOBAL EDUCATION INC. November 12, 2025 Ratify selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026.
Audit-related
Board For FOR
1 fund
Split
3 FOR, 2 ABSTAIN
ADTALEM GLOBAL EDUCATION INC. November 12, 2025 Say-on-pay: Advisory vote to approve the compensation of our named executive officers.
Say-on-Pay
Board For FOR
1 fund
Split
3 FOR, 2 ABSTAIN
ADVANCED ENERGY INDUSTRIES, INC. May 7, 2026 Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares;
Capital Structure
Board For FOR
1 fund
Split
8 FOR, 3 AGAINST
ADVANCED ENERGY INDUSTRIES, INC. May 7, 2026 Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan;
Compensation
Board For AGAINST
1 fund
Split
3 FOR, 5 AGAINST, 3 ABSTAIN
ADVANCED ENERGY INDUSTRIES, INC. May 7, 2026 Ratification of the appointment of Ernst & Young LLP as Advanced Energy's independent registered public accounting firm for 2026;
Audit-related
Board For FOR
1 fund
Split
8 FOR, 3 ABSTAIN
ADVANCED MICRO DEVICES, INC. May 13, 2026 Approve an amendment and restatement of the Advanced Micro Devices, Inc. 2023 Equity Incentive Plan.
Compensation
Board For FOR
5 funds
Split
9 FOR, 6 ABSTAIN
ADVANCED MICRO DEVICES, INC. May 13, 2026 Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the current fiscal year.
Audit-related
Board For FOR
5 funds
Split
8 FOR, 1 AGAINST, 6 ABSTAIN
AENA SME SA April 16, 2026 REELECT MAURICI LUCENA BETRIU AS DIRECTOR
Director Elections
Board For AGAINST
5 funds
Split
1 FOR, 3 AGAINST
AEROVIRONMENT, INC. September 25, 2025 Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan
Compensation
Board For FOR
1 fund
Split
4 FOR, 3 ABSTAIN
AEROVIRONMENT, INC. September 25, 2025 Non-binding advisory vote on the compensation of the company's Named Executive Officers:
Say-on-Pay
Board For FOR
1 fund
Split
4 FOR, 3 ABSTAIN
AEROVIRONMENT, INC. September 25, 2025 To ratify the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2026:
Audit-related
Board For FOR
1 fund
Split
4 FOR, 3 ABSTAIN
AES CORP April 29, 2026 Approval, on an advisory basis, of the Company's executive compensation.
Say-on-Pay
Board For FOR
2 funds
Split
5 FOR, 1 ABSTAIN
AFFILIATED MANAGERS GROUP, INC. May 27, 2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
3 funds
Split
5 FOR, 2 ABSTAIN
AFFILIATED MANAGERS GROUP, INC. May 27, 2026 To elect seven directors of the Company to serve until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. G. Staley Cates
Director Elections
Board For FOR
3 funds
Split
5 FOR, 2 ABSTAIN
AFFILIATED MANAGERS GROUP, INC. May 27, 2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year.
Audit-related
Board For FOR
3 funds
Split
5 FOR, 2 ABSTAIN
AFFIRM HOLDINGS, INC. December 15, 2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
4 funds
Split
3 FOR, 1 AGAINST, 2 ABSTAIN
AFFIRM HOLDINGS, INC. December 15, 2025 To ratify the Audit Committee's selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.
Audit-related
Board For FOR
3 funds
Split
4 FOR, 2 ABSTAIN
AFLAC INCORPORATED May 4, 2026 To elect as Directors of the Company the eleven nominees named in the accompanying Proxy Statement to serve until the next Annual Meeting and until their successors are duly elected and qualified: Daniel P. Amos
Director Elections
Board For FOR
2 funds
Split
4 FOR, 1 ABSTAIN
AFLAC INCORPORATED May 4, 2026 to consider and act upon the ratification of the appointment of KPMG LLP as independent registered public accounting firm of the Company for the year ending December 31, 2026
Audit-related
Board For FOR
2 funds
Split
4 FOR, 1 AGAINST, 1 ABSTAIN
AGILENT TECHNOLOGIES, INC. March 18, 2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Judy Gawlik Brown
Director Elections
Board For FOR
4 funds
Split
8 FOR, 3 ABSTAIN
AGILENT TECHNOLOGIES, INC. March 18, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
7 funds
Split
8 FOR, 1 AGAINST, 3 ABSTAIN
AGILENT TECHNOLOGIES, INC. March 18, 2026 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
Audit-related
Board For FOR
4 funds
Split
8 FOR, 1 AGAINST, 3 ABSTAIN
AGILYSYS, INC. September 4, 2025 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement
Say-on-Pay
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Dana Jones
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Donald A. Colvin
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Jerry Jones
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: John Mutch
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Lisa Pope
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Melvin L. Keating
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Michael A. Kaufman
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Election of Directors: Ramesh Srinivasan
Director Elections
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGILYSYS, INC. September 4, 2025 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026
Audit-related
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
AGIOS PHARMACEUTICALS, INC. June 18, 2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares.
Compensation
Board For FOR
1 fund
Split
2 FOR, 1 ABSTAIN
AGIOS PHARMACEUTICALS, INC. June 18, 2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified. Rahul Ballal, Ph.D.
Director Elections
Board For FOR
1 fund
Split
1 FOR, 1 WITHHOLD
AGIOS PHARMACEUTICALS, INC. June 18, 2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
1 fund
Split
2 FOR, 1 ABSTAIN
AGIOS PHARMACEUTICALS, INC. June 18, 2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers.
Say-on-Pay
Board For FOR
1 fund
Split
2 FOR, 1 ABSTAIN
AGREE REALTY CORPORATION May 14, 2026 To approve, by non-binding vote, executive compensation.
Say-on-Pay
Board For FOR
2 funds
Split
3 FOR, 1 AGAINST, 2 ABSTAIN
AGREE REALTY CORPORATION May 14, 2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026.
Audit-related
Board For FOR
1 fund
Split
4 FOR, 2 ABSTAIN
AIR LEASE CORPORATION December 18, 2025 Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal'').
Say-on-Pay
Board For FOR
1 fund
Split
2 FOR, 2 ABSTAIN
AIR PRODUCTS AND CHEMICALS, INC. January 28, 2026 Advisory vote approving the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
8 funds
Split
5 FOR, 1 ABSTAIN
AIR PRODUCTS AND CHEMICALS, INC. January 28, 2026 Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2026.
Audit-related
Board For FOR
7 funds
Split
5 FOR, 1 ABSTAIN
AIRBNB INC June 5, 2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
3 funds
Split
6 FOR, 2 AGAINST, 3 ABSTAIN
AIRBNB INC June 5, 2026 To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk.
Director Elections
Board For WITHHOLD
3 funds
Split
1 FOR, 4 WITHHOLD
AIRBNB INC June 5, 2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
3 funds
Split
8 FOR, 3 ABSTAIN
AKER BP ASA April 21, 2026 Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights
Capital Structure
Board For AGAINST
2 funds
Split
1 FOR, 2 AGAINST
AKER BP ASA April 21, 2026 Authorize Share Repurchase Program and Reissuance of Repurchased Shares
Capital Structure
Board For AGAINST
2 funds
Split
1 FOR, 2 AGAINST
AKER BP ASA April 21, 2026 Reelect Charles Ashley Heppenstall as Director
Director Elections
Board For AGAINST
2 funds
Split
1 FOR, 2 AGAINST
AKER BP ASA April 21, 2026 Reelect Doris Reiter as Director
Director Elections
Board For AGAINST
2 funds
Split
1 FOR, 2 AGAINST
AKER BP ASA April 21, 2026 Reelect Oyvind Eriksen (Chair) as Director
Director Elections
Board For AGAINST
2 funds
Split
1 FOR, 2 AGAINST
AKZO NOBEL NV April 23, 2026 Approve Supplement to Remuneration Policy in Respect of M.J. de Vries
Compensation
Board For Split
4 FOR, 2 AGAINST
Split
2 FOR, 3 AGAINST
ALAMO GROUP INC. May 1, 2026 Proposal FOR approval of the advisory vote on the compensation of the named executive officers.
Say-on-Pay
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
ALAMO GROUP INC. May 1, 2026 Proposal FOR ratification of the appointment of KPMG LLP as the Company's Independent Auditors for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
1 fund
Split
5 FOR, 1 ABSTAIN
ALBEMARLE CORPORATION May 5, 2026 Advisory vote to approve the compensation of our named executive officers.
Say-on-Pay
Board For FOR
2 funds
Split
3 FOR, 3 ABSTAIN
ALBERTSONS COMPANIES, INC. August 7, 2025 Hold the annual, non-binding, advisory vote on our executive compensation program.
Say-on-Pay
Board For FOR
3 funds
Split
2 FOR, 2 ABSTAIN
ALCON SA April 30, 2026 Reelect Michael Ball as Director and Board Chair
Director Elections
Board For Split
3 FOR, 1 AGAINST
FOR
4 funds
ALEXANDRIA REAL ESTATE EQUITIES, INC. May 13, 2026 To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement.
Say-on-Pay
Board For FOR
1 fund
Split
3 FOR, 1 ABSTAIN
ALEXANDRIA REAL ESTATE EQUITIES, INC. May 13, 2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2026, as more particularly described in the accompanying Proxy Statement.
Audit-related
Board For FOR
1 fund
Split
3 FOR, 1 ABSTAIN
ALIMENTATION COUCHE-TARD INC September 3, 2025 ELECTION OF DIRECTOR: MELANIE KAU
Director Elections
Board For WITHHOLD
1 fund
Split
1 FOR, 1 WITHHOLD
ALKAMI TECHNOLOGY INC May 19, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers, or NEOs.
Say-on-Pay
Board For FOR
1 fund
Split
1 FOR, 1 ABSTAIN
ALKAMI TECHNOLOGY INC May 19, 2026 To ratify the appointment by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.
Audit-related
Board For FOR
1 fund
Split
1 FOR, 1 ABSTAIN
ALKERMES PLC May 20, 2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
Compensation
Board For FOR
2 funds
Split
7 FOR, 2 ABSTAIN
ALKERMES PLC May 20, 2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
2 funds
Split
7 FOR, 2 ABSTAIN
ALKERMES PLC May 20, 2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration.
Audit-related
Board For FOR
2 funds
Split
7 FOR, 2 ABSTAIN
ALKERMES PLC May 20, 2026 To renew Board authority to allot and issue shares under Irish law.
Capital Structure
Board For FOR
2 funds
Split
7 FOR, 2 AGAINST
ALKERMES PLC May 20, 2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.
Capital Structure
Board For FOR
2 funds
Split
7 FOR, 2 AGAINST
ALLEGION PLC June 4, 2026 Approve the compensation of our named executive officers on an advisory (non-binding) basis.
Say-on-Pay
Board For FOR
5 funds
Split
5 FOR, 1 AGAINST, 3 ABSTAIN
ALLEGION PLC June 4, 2026 Ratify the appointment of our independent registered public accounting firm and authorize the Audit and Finance Committee of the Board of Directors to set the independent registered public accounting firm's remuneration for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
4 funds
Split
6 FOR, 3 ABSTAIN
ALLIANT ENERGY CORPORATION May 20, 2026 Advisory vote to approve the compensation of our named executive officers
Say-on-Pay
Board For FOR
2 funds
Split
7 FOR, 2 ABSTAIN
ALLIANT ENERGY CORPORATION May 20, 2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026
Audit-related
Board For FOR
2 funds
Split
7 FOR, 2 ABSTAIN
ALLISON TRANSMISSION HOLDINGS, INC. May 6, 2026 An advisory non-binding vote to approve the compensation paid to our named executive officers.
Say-on-Pay
Board For FOR
3 funds
Split
4 FOR, 1 ABSTAIN
ALLISON TRANSMISSION HOLDINGS, INC. May 6, 2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.
Audit-related
Board For FOR
2 funds
Split
4 FOR, 1 ABSTAIN
ALLY FINANCIAL INC. May 6, 2026 Approval of the Ally Financial Inc. Employee Stock Purchase Plan.
Compensation
Board For FOR
1 fund
Split
4 FOR, 3 AGAINST
ALLY FINANCIAL INC. May 6, 2026 Approval of the Ally Financial Inc. Incentive Compensation Omnibus Plan.
Compensation
Board For FOR
1 fund
Split
4 FOR, 3 ABSTAIN
ALLY FINANCIAL INC. May 6, 2026 Ratification of the Audit Committee's engagement of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.
Audit-related
Board For FOR
1 fund
Split
4 FOR, 3 ABSTAIN
ALNYLAM PHARMACEUTICALS, INC. May 20, 2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.
Say-on-Pay
Board For FOR
4 funds
Split
6 FOR, 4 ABSTAIN
ALNYLAM PHARMACEUTICALS, INC. May 20, 2026 To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D.
Director Elections
Board For FOR
4 funds
Split
2 FOR, 1 AGAINST
ALNYLAM PHARMACEUTICALS, INC. May 20, 2026 To elect the following nominees as Class I directors of Alnylam: Stuart A. Arbuckle
Director Elections
Board For FOR
4 funds
Split
2 FOR, 1 AGAINST
ALNYLAM PHARMACEUTICALS, INC. May 20, 2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026.
Audit-related
Board For FOR
4 funds
Split
5 FOR, 1 AGAINST, 4 ABSTAIN
ALPHABET INC. June 5, 2026 Advisory vote to approve compensation awarded to named executive officers
Say-on-Pay
Board For AGAINST
19 funds
Split
5 FOR, 11 AGAINST, 8 ABSTAIN
ALPHABET INC. June 5, 2026 Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock
Compensation
Board For AGAINST
15 funds
Split
10 FOR, 6 AGAINST, 8 ABSTAIN
ALPHABET INC. June 5, 2026 Election of ten directors: Frances H. Arnold
Director Elections
Board For AGAINST
15 funds
Split
3 FOR, 7 AGAINST
ALPHABET INC. June 5, 2026 Election of ten directors: John L. Hennessy
Director Elections
Board For AGAINST
15 funds
Split
3 FOR, 7 AGAINST
ALPHABET INC. June 5, 2026 Election of ten directors: K. Ram Shriram
Director Elections
Board For Split
14 FOR, 1 AGAINST
FOR
10 funds
ALPHABET INC. June 5, 2026 Election of ten directors: L. John Doerr
Director Elections
Board For Split
14 FOR, 1 AGAINST
FOR
10 funds
ALPHABET INC. June 5, 2026 Election of ten directors: Robin L. Washington
Director Elections
Board For Split
14 FOR, 1 AGAINST
FOR
10 funds

← Previous Page 9 of 80 Next →

← All 20 managers, 2025-2026

How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.